These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 2417060)

  • 1. [Presynaptic effects of aminopyridines on the neuromuscular junction of vertebrates].
    Molgó J; Lemeignan M; Peradejordi F; Lechat P
    J Pharmacol; 1985; 16 Suppl 2():109-44. PubMed ID: 2417060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 4-aminopyridine and 3,4-diaminopyridine on transmitter release at the neuromuscular junction.
    Thomsen RH; Wilson DF
    J Pharmacol Exp Ther; 1983 Oct; 227(1):260-5. PubMed ID: 6137556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in transmitter release from motor nerve terminals induced by some pyridine derivatives.
    Montoya GA; Molgó J; Lemeignan M; Lechat P
    Acta Physiol Pharmacol Latinoam; 1984; 34(4):409-18. PubMed ID: 6242265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 4-aminopyridine on neuromuscular transmission.
    Lundh H
    Brain Res; 1978 Sep; 153(2):307-18. PubMed ID: 210882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the facilitatory actions of 4-aminopyridine methiodide and 4-aminopyridine on neuromuscular transmission.
    Horn AS; Lambert JJ; Marshall IG
    Br J Pharmacol; 1979 Jan; 65(1):53-62. PubMed ID: 216450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presynaptic effects of bekanamycin at the frog neuromuscular junction. Reversibility by calcium and aminopyridines.
    Uchiyama T; Molgo J; Lemeignan M
    Eur J Pharmacol; 1981 Jul; 72(4):271-80. PubMed ID: 6268416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facilitatory effects of 4-aminopyridine on normal neuromuscular transmission.
    Kim YI; Goldner MM; Sanders DB
    Muscle Nerve; 1980; 3(2):105-11. PubMed ID: 6245354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of quantal transmitter release caused by gadolinium ions at the frog neuromuscular junction.
    Molgó J; del Pozo E; Baños JE; Angaut-Petit D
    Br J Pharmacol; 1991 Sep; 104(1):133-8. PubMed ID: 1686201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electronic properties of motor nerve terminals.
    Molgó J; Thesleff S
    Acta Physiol Scand; 1982 Feb; 114(2):271-5. PubMed ID: 6291327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of kanamycin on evoked transmitter release. Reversal by 3,4-diaminopyridine.
    Molgó J; Lemeignan M; Uchiyama T; Lechat P
    Eur J Pharmacol; 1979 Jul; 57(1):93-7. PubMed ID: 38977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminoglycosides and 3,4-diaminopyridine on neuromuscular block caused by botulinum type A toxin.
    Molgó J; Lemeignan M; Thesleff S
    Muscle Nerve; 1987 Jun; 10(5):464-70. PubMed ID: 3497343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facilitatory effects of 4-aminopyridine on strontium-mediated evoked and delayed transmitter release from motor nerve terminals.
    Molgó J; Lemeignan M; Guerrero S
    Eur J Pharmacol; 1982 Oct; 84(1-2):1-7. PubMed ID: 6128233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of cholinergic compounds on spontaneous quantal mediator release at the neuromuscular synapse of the frog].
    Bukharaeva EA; Nikol'skiĭ EE; Giniatullin RA
    Neirofiziologiia; 1986; 18(5):586-93. PubMed ID: 2877404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-Aminopyridine and evoked transmitter release from motor nerve endings.
    Illes P; Thesleff S
    Br J Pharmacol; 1978 Dec; 64(4):623-9. PubMed ID: 31961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in presynaptic action of 4-aminopyridine and tetraethylammonium at frog neuromuscular junction.
    Glavinović MI
    Can J Physiol Pharmacol; 1987 May; 65(5):747-52. PubMed ID: 2887267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the action of 4-aminopyridine during repetitive stimulation at the neuromuscular junction.
    Molgó J; Lemeignan M; Lechat P
    Eur J Pharmacol; 1979 Jan; 53(3):307-11. PubMed ID: 32061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-Aminopyridine does not increase m.e.p.p. frequencies at junctions depolarized by potassium.
    van der Kloot W; Madden KS
    Brain Res; 1981 Apr; 210(1-2):467-70. PubMed ID: 6971693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic interaction of 4-aminopyridine with neostigmine at the neuromuscular junction.
    Tierney PC; Kim YI; Johns TR
    Eur J Pharmacol; 1985 Sep; 115(2-3):241-7. PubMed ID: 2998823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of charybdotoxin, a blocker of Ca2+-activated K+ channels, on motor nerve terminals.
    Anderson AJ; Harvey AL; Rowan EG; Strong PN
    Br J Pharmacol; 1988 Dec; 95(4):1329-35. PubMed ID: 2464391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation by 4-aminopyridine of quantal acetylcholine release at the Torpedo nerve-electroplaque junction.
    Muller D
    J Physiol; 1986 Oct; 379():479-93. PubMed ID: 3031284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.